In the project, a self-generated CEACAM5-specific nanobody is used for the targeted functionalization of the Pacuna VLP delivery platform. The VLPs are loaded with RNA and validated for specific binding, cellular uptake, and functional RNA delivery in CEACAM5-positive cells. The goal is the proof of concept for Pacuna's modular, nanobody-controlled VLP delivery technology.

IseeIT places IT professionals with EU passports in permanent positions, specializing in four niches: Cybersecurity, Cloud, DevOps, and Platform Engineering. Instead of selling candidates a path, we fully calculate both options (Germany and Switzerland) with our own comparison tool and then personally assist with settling in. This is always free for candidates; companies pay based on success only upon placement. This is made possible by the combination of niche specialization and direct language access in German, English, Spanish, and Greek to candidate markets that large generalists cannot reach operationally at scale. Rationally calculated, humanly accompanied.

We are seeking partners in Lower Saxony to support the development and validation of VARAXIS, an early-stage multimodal wearable platform for longitudinal cardiovascular monitoring. Key challenges include robust acquisition and synchronization of SCG and PPG signals, signal-quality and artifact management, wearable hardware integration, and the design and execution of clinically meaningful validation studies. We are particularly interested in cooperation with MedTech, sensor and embedded-systems specialists, hospitals, universities, and research organizations capable of supporting prototype development, technical validation, clinical research, and regulatory preparation.